Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Morand

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Inflammation|January 16, 1998
Antiinflammatory effect of lipocortin 1 in experimental arthritisY Yang, M Leech, P Hutchinson, et al.
Lupus|July 13, 2013
Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosusF B Vincent, M Northcott, A Hoi, et al.
Clinical and Experimental Immunology|March 18, 2008
Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylationL L Santos, A Dacumos, J Yamana, et al.
Inflammation|June 1, 1997
Suppression of adjuvant arthritis and synovial macrophage inducible nitric oxide by N-iminoethyl-L-ornithine, a nitric oxide synthase inhibitorL L Santos, E F Morand, Y Yang, et al.
Arthritis and Rheumatism|February 1, 1994
Impaired glucocorticoid induction of mononuclear leukocyte lipocortin-1 in rheumatoid arthritisE F Morand, C M Jefferiss, J Dixey, et al.
Scientific Reports|July 26, 2016
Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosusK L Connelly, R Kandane-Rathnayake, A Hoi, et al.
Rheumatology (Oxford, England)|May 20, 1999
Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosusY Kipen, E M Briganti, B J Strauss, et al.
Clinical and Experimental Immunology|February 1, 1997
Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritisL L Santos, E F Morand, P Hutchinson, et al.
Rheumatology (Oxford, England)|May 16, 2002
Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlationsE F Morand, M Leech, H Weedon, et al.
Lupus Science & Medicine|April 21, 2015
Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohortK S Yap, M Northcott, A B-Y Hoi, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Inflammation|January 16, 1998
Antiinflammatory effect of lipocortin 1 in experimental arthritisY Yang, M Leech, P Hutchinson, et al.
Lupus|July 13, 2013
Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosusF B Vincent, M Northcott, A Hoi, et al.
Clinical and Experimental Immunology|March 18, 2008
Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylationL L Santos, A Dacumos, J Yamana, et al.
Inflammation|June 1, 1997
Suppression of adjuvant arthritis and synovial macrophage inducible nitric oxide by N-iminoethyl-L-ornithine, a nitric oxide synthase inhibitorL L Santos, E F Morand, Y Yang, et al.
Arthritis and Rheumatism|February 1, 1994
Impaired glucocorticoid induction of mononuclear leukocyte lipocortin-1 in rheumatoid arthritisE F Morand, C M Jefferiss, J Dixey, et al.
Scientific Reports|July 26, 2016
Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosusK L Connelly, R Kandane-Rathnayake, A Hoi, et al.
Rheumatology (Oxford, England)|May 20, 1999
Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosusY Kipen, E M Briganti, B J Strauss, et al.
Clinical and Experimental Immunology|February 1, 1997
Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritisL L Santos, E F Morand, P Hutchinson, et al.
Rheumatology (Oxford, England)|May 16, 2002
Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlationsE F Morand, M Leech, H Weedon, et al.
Lupus Science & Medicine|April 21, 2015
Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohortK S Yap, M Northcott, A B-Y Hoi, et al.
Pageof 6